Septic arthritis: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
* Def: inflammation of a synovial membrane with purulent effusion into the joint capsule | * Def: inflammation of a synovial membrane with purulent effusion into the joint capsule | ||
| Line 40: | Line 39: | ||
==DDx== | ==DDx== | ||
# toxic synovitis | |||
# abscess | |||
# cellulitis | |||
# primary rheumatologic disorder (i.e. vasculitis) | |||
# iatrogenic | |||
# reactive arthritis (post infectious) | |||
==Gonococcal Arthritis== | ==Gonococcal Arthritis== | ||
| Line 58: | Line 57: | ||
==Arthritis-Dermatitis Syndrome== | ==Arthritis-Dermatitis Syndrome== | ||
===Diagnosis=== | ===Diagnosis=== | ||
#Triad: dermatitis, tenosynovitis, migratory polyarthritis (hematogenous spread of bacteria and immune complexes) | |||
#Skin lesions: scattered small painless erythematous macules or petechiae-->pustular -->necrotic lesions | |||
#Transient painful extensor tenosynovitis (writs, hands, ankles) | |||
#Asymmtric polyarthralgia of extremity joints | |||
#Diagnosis Cx everything - jt, mucosal surfaces, lesions | |||
===Treatment=== | ===Treatment=== | ||
| Line 78: | Line 73: | ||
===Background=== | ===Background=== | ||
Fulminant presentation (abrupt, swelling, toxicity and fever) unless elderly | Fulminant presentation (abrupt, swelling, toxicity and fever) unless elderly | ||
#Hematogenous | |||
#Contiguous | |||
#Direct traumatic implantation | |||
#Postop | |||
===Causes=== | ===Causes=== | ||
Bacterial | #Bacterial | ||
#Mycobacterial | |||
Mycobacterial | #Spirochete (lyme, syphilis) | ||
#Fungal | |||
Spirochete (lyme, syphilis) | #Viral (HIV, Hep B, Rubella, etc) | ||
#Postinfectious | |||
Fungal | |||
Postinfectious | |||
===Diagnosis=== | ===Diagnosis=== | ||
Synovial fluid aspiration | #Synovial fluid aspiration | ||
#Cx - if only one test, use BCx bottles (may enhance yield) | |||
Cx - if only one test, use BCx bottles (may enhance yield) | #Grm stain - 80% positive in gram-positive infxn; less sens in gram-negative | ||
#Cell count with dif - >50,000-150,000; PMN > 90% | |||
Grm stain - 80% positive in gram-positive infxn; less sens in gram-negative | |||
Cell count with dif - >50,000-150,000; PMN > 90% | |||
===Treatment=== | ===Treatment=== | ||
PCN-ase resistant synthetic PCN: | #PCN-ase resistant synthetic PCN: | ||
##Nafcillin 1-2g | |||
Nafcillin 1-2g | ##Cefazolin 1-2g | ||
Cefazolin 1-2g | |||
AND | AND | ||
3rd gen ceph | 3rd gen ceph | ||
| Line 129: | Line 109: | ||
==Treatment== | ==Treatment== | ||
# drainage of the joint | |||
# IV Antibiotics | |||
# generally Oxacillin or Nafcillin with a cephalosporin (ceftriaxone, feotaxme, ceftizoxime) will cover | |||
# add vancomycin if you suspect MRSA | |||
# in IVDA patients use IV aminoglycoside + antipseudomonal cephalosporin | |||
# patients with prosthetic joints are at higher risk of MRSA, MRSE, Enterobacteriaceae, and Pseudomonas | |||
# consider gonococcal infection in young sexually active patients (treat with ceftriaxone) | |||
# Open drainage and lavage in the OR | |||
==Disposition== | ==Disposition== | ||
Revision as of 20:08, 15 November 2011
Background
- Def: inflammation of a synovial membrane with purulent effusion into the joint capsule
- usually affects monoarticular joints (the knee is most commonly affected in adults and the hip in children)
- Relatively rare disease however because it can quickly destroy the joint or lead to osteomyelitis, fibrous ankylosis, sepsis, or even death it is important to catch and treat promptly
- Frequency is ~20,000 cases in USA/year (may be higher in pts with immunologic disorders (RA, SLE))
- M>F predominance, usually in patients >65 years
- Etiology is usually bacterial, divided into gonococcal or nongonococcal groups
- staph and strep are most common nongonococcal causes
- consider different organisms in children, IV drug users, and those with prosthetic joints
Diagnosis
- may be difficult to diagnose in early stages
- patient typically presents with fever and a warm, red, painful, swollen joint with decreased range of motion even passively
- confirm diagnosis with work up
Infected fluid characteristics
- large amount (>3.5 mL)
- turbid in appearance
- decreased viscosity
- 15,000->200,000 leukocytes/cubic cm (15-200 x 10^9 per L)
- Likelyhood ratios:
- 0-25,000 = 0.33
- 25,000-50,000 = 1.06
- 50,000-100,000 = 3.59
- >100,000 = infinity
- Likelyhood ratios:
- 50-100% PMNs
- Poor mucin clot
- glucose >40mg/100mL less than plasma glucose
- Positive culture
Work-Up
- CBC
- ESR
- Blood Cultures
- Gonorrhea culture (urethral/cervical/pharyngeal/rectal)
- Arthrocentesis with synovial fluid analysis
- Plain films (often normal but may show widening of joint space or evidence of osteomyelitis)
- Ultrasound (can show joint effusion, extent of disease, and may help differentiate from other conditions)
DDx
- toxic synovitis
- abscess
- cellulitis
- primary rheumatologic disorder (i.e. vasculitis)
- iatrogenic
- reactive arthritis (post infectious)
Gonococcal Arthritis
Healthy, young sexually active adults
Women > men
Suppurative monoarthritis (may be preceded by polyarthralgias)
Knee, wrist, ankle
Arthritis-Dermatitis Syndrome
Diagnosis
- Triad: dermatitis, tenosynovitis, migratory polyarthritis (hematogenous spread of bacteria and immune complexes)
- Skin lesions: scattered small painless erythematous macules or petechiae-->pustular -->necrotic lesions
- Transient painful extensor tenosynovitis (writs, hands, ankles)
- Asymmtric polyarthralgia of extremity joints
- Diagnosis Cx everything - jt, mucosal surfaces, lesions
Treatment
CTX 1gIV qd OR
Cefotax 1g q8
Empirically treat Chlamydia
Nongonococcal Arthritis
Background
Fulminant presentation (abrupt, swelling, toxicity and fever) unless elderly
- Hematogenous
- Contiguous
- Direct traumatic implantation
- Postop
Causes
- Bacterial
- Mycobacterial
- Spirochete (lyme, syphilis)
- Fungal
- Viral (HIV, Hep B, Rubella, etc)
- Postinfectious
Diagnosis
- Synovial fluid aspiration
- Cx - if only one test, use BCx bottles (may enhance yield)
- Grm stain - 80% positive in gram-positive infxn; less sens in gram-negative
- Cell count with dif - >50,000-150,000; PMN > 90%
Treatment
- PCN-ase resistant synthetic PCN:
- Nafcillin 1-2g
- Cefazolin 1-2g
AND 3rd gen ceph
OR
Vanc^
^new evidence suggests significantly increased rate of MRSA septic arthritis
^^cell counts are as low as 20,000 in MRSA Cx + synovial fluid
Treatment
- drainage of the joint
- IV Antibiotics
- generally Oxacillin or Nafcillin with a cephalosporin (ceftriaxone, feotaxme, ceftizoxime) will cover
- add vancomycin if you suspect MRSA
- in IVDA patients use IV aminoglycoside + antipseudomonal cephalosporin
- patients with prosthetic joints are at higher risk of MRSA, MRSE, Enterobacteriaceae, and Pseudomonas
- consider gonococcal infection in young sexually active patients (treat with ceftriaxone)
- Open drainage and lavage in the OR
Disposition
- All patients should be admitted with Ortho consult and continued on IV antibiotics
See Also
Source
http://emprocedures.com/arthrocentesis/analysis.htmEmedicine
